[1]
E. van Duuren, “South African Rheumatism and Arthritis Association 2024 guidelines for the use of biologic and targeted synthetic disease-modifying antirheumatic drugs”, S Afr Med J, vol. 114, no. 9, p. e2599, Sep. 2024, doi: 10.7196/SAMJ.2024.v114i10.2599.